Abstract
Nina Hallowell was a medical sociologist, Professor of Social and Ethical Aspects of Genomics at the University of Oxford, and an active member of the editorial board of Health, Risk & Society. In this article I reflect on her contribution to the journal and to the interdisciplinary study of risk especially through her research on the risk of new genetic technologies, both its management and impact on those at-risk.
Disclosure statement
No potential conflict of interest was reported by the author(s).